A Study of the Natural History and Clinical Characteristics of Nephronophthisis (a Genetic Kidney Disease)

Overview

About this study

The purpose of this study is to evaluate and better understand the natural history, clinical characteristics and outcomes of Nephronophthisis, a genetically linked kidney disease that progresses to end stage before the age of 30.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Diagnosis with Nephronophthisis 

Exclusion Criteria 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Marie Hogan, M.D., Ph.D.

Closed for enrollment

Contact information:

Marie Hogan M.D., Ph.D.

(507)266-1044

Hogan.Marie@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20301841

Mayo Clinic Footer